Suboptimal response to or failure of imatinib treatment for chronic myeloid leukemia: What is the optimal strategy?

Elias Jabbour, Jorge E. Cortes, Hagop M. Kantarjian

Research output: Contribution to journal › Review article › peer-review

42 Scopus citations

Fingerprint

Dive into the research topics of 'Suboptimal response to or failure of imatinib treatment for chronic myeloid leukemia: What is the optimal strategy?'. Together they form a unique fingerprint.

Keyphrases

Nursing and Health Professions

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science